The impact of Medicare Part D on psychotropic utilization and financial burden for community-based seniors

Psychiatric Services

Volumn 59, Issue 10, 2008, Pages 1191-1197

  Chen, Hua ^a   Nwangwu, Afam ^a   Aparasu, Rajender ^a   Essien, Ekere ^a   Sun, Shawn ^b   Lee, Kwan ^b  

^a UNIVERSITY OF HOUSTON   (United States)

^b Walgreens Health Services   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; BENZODIAZEPINE; NEUROLEPTIC AGENT;

AGED; ARTICLE; CONTROLLED STUDY; DRUG COST; DRUG LEGISLATION; DRUG USE; DRUG UTILIZATION; ELDERLY CARE; FEMALE; HUMAN; MALE; MEDICARE; MENTAL HEALTH CARE; PRESCRIPTION; REIMBURSEMENT;

EID: 53549096817     PISSN: 10752730     EISSN: 15579700     Source Type: Journal    
DOI: 10.1176/ps.2008.59.10.1191     Document Type: Article

References (21)

1. Donohue JM: Mental health in the Medicare drug benefit: a new regulatory model? Health Affairs 25:707-719, 2006
2. Aparasu RR, Mort JR, Brandt H: Psychotropic prescription use by community-dwelling elderly in the United States. Journal of the American Geriatrics Society 51:671-677, 2003
3. Aparasu RR, Mort JR, Sitzman S: Psychotropic prescribing for the elderly in office-based practice. Clinical Therapeutics 20:603-616, 1998
4. Pincus H, Tanielian TL, Marcus SC, et al: Prescribing trends in psychotropic medications: primary care, psychiatric, and other medical specialities. JAMA 279:526-531, 1998
5. Egberts ACG, Leufkens HGM, Hofman A, et al: Incidence of antidepressant drug use in older adults and association with chronic diseases: the Rotterdam Study. International Clinical Psychopharmacology 12:217-223, 1997
6. Lakey SL, Gray SL, Sales AE et al: Psychotropic use in community residential care facilities: a prospective cohort study. American Journal of Geriatric Pharmacotherapy 4:227-235, 2006
7. Levit K, Smith C, Cowan C, et al: Health spending rebound continues in 2002. Health Affairs 23:147-159, 2004
8. Mark TL, Buck JA, Dilonardo JD, et al: Medicaid expenditures on behavioral health care. Psychiatric Services 54:188-194, 2003
9. Lichtenberg FR, Sun S: The impact of Medicare Part D on prescription drug use by the elderly. Health Affairs 26:1735-1744, 2007
10. Bambauer KZ, Sabin JE, Soumerai SB: The exclusion of benzodiazepine coverage in Medicare: simple steps for avoiding a public health crisis. Psychiatric Services 56:1143-1146, 2005
11. Clearing Hurdles and Hitting Walls: Restrictions Undermine Part D Coverage of Mental Health Drugs. Washington, DC, Medicare Rights Center, Sept 2006. Available at www.medicarerights.org
12. Morden N, Garrison L: Implications of Part D for mentally ill dual eligibles: a challenge for Medicare. Health Affairs 25:491-500, 2006
13. Medicare Low-Income Assistance Under the Medicare Drug Benefit. Menlo Park, Calif, Henry J Kaiser Family Foundation, May 2006. Available at www.kff.org
14. Medicare prescription drug coverage among Medicare beneficiaries. Menlo Park, Calif, Henry J Kaiser Family Foundation, June 2006. Available at www.kff.org
15. Zuckerman IH, Lee E, Wutoh AK, et al: Application of regression- discontinuity analysis in pharmaceutical health services research. Health Services Research 41:550-563, 2006
16. Wagner AK, Soumerai SB, Zhang F, et al: Segmented regression analysis of interrupted time series studies in medication use research. Journal of Clinical Pharmacy and Therapeutics 27:299-309, 2002
17. Hartung DM, Touchette DR, Ketchum KL, et al: Effects of a prior-authorization policy for celecoxib on medical service and prescription drug use in a managed care Medicare population. Clinical Therapeutics 26:1518-1532, 2004
18. Offerhaus L: Drugs for Elderly. Geneva, World Health Organization, 1997
19. Beers MH: Explicit criteria for determining potentially inappropriate medication use by the elderly: an update. Archives of Internal Medicine 157:1531-1536,1997
20. Fick DM, Cooper JW, Wade WE, et al: Updating the Beer's criteria for potentially inappropriate medication use in older adults. Archives of Internal Medicine 163:2716-2724, 2003
21. Stuart B, Briesacher BA, Shea DG, et al: Riding the rollercoaster: the ups and downs in out-of-pocket spending under the standard Medicare drug benefit. Health Affairs 24:1022-1031, 2005